one8zero8 LLC Has $2.77 Million Position in Revvity Inc. (NYSE:RVTY)

Key Points

• one8zero8 LLC has reduced its stake in Revvity Inc. by 16.7%, selling 5,250 shares in the first quarter, leaving them with 26,206 shares valued at $2,773,000.
• Analysts have mixed views on Revvity, with ratings changing from "neutral" to "buy," and a consensus price target of $123.07 based on recent reports from various firms.
• Revvity plans to pay a quarterly dividend of $0.07 per share on November 7th, representing an annualized dividend of $0.28 and a yield of 0.27%.

one8zero8 LLC cut its holdings in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 16.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 26,206 shares of the company's stock after selling 5,250 shares during the period. one8zero8 LLC's holdings in Revvity were worth $2,773,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Raymond James Financial Inc. bought a new stake in shares of Revvity in the fourth quarter valued at about $2,248,000. HighTower Advisors LLC lifted its holdings in shares of Revvity by 21.1% in the fourth quarter. HighTower Advisors LLC now owns 6,415 shares of the company's stock valued at $716,000 after purchasing an additional 1,117 shares in the last quarter. Korea Investment CORP raised its holdings in Revvity by 74.8% during the fourth quarter. Korea Investment CORP now owns 54,665 shares of the company's stock worth $6,101,000 after acquiring an additional 23,400 shares in the last quarter. Elo Mutual Pension Insurance Co raised its holdings in Revvity by 18.8% during the fourth quarter. Elo Mutual Pension Insurance Co now owns 13,019 shares of the company's stock worth $1,453,000 after acquiring an additional 2,059 shares in the last quarter. Finally, UniSuper Management Pty Ltd raised its holdings in Revvity by 24.9% during the fourth quarter. UniSuper Management Pty Ltd now owns 18,399 shares of the company's stock worth $2,054,000 after acquiring an additional 3,671 shares in the last quarter. 86.65% of the stock is currently owned by institutional investors.

Revvity Stock Performance

Shares of Revvity stock traded down $8.59 on Monday, hitting $95.08. The stock had a trading volume of 4,794,295 shares, compared to its average volume of 1,137,969. Revvity Inc. has a twelve month low of $87.70 and a twelve month high of $129.50. The business's 50 day moving average is $95.53 and its two-hundred day moving average is $103.26. The company has a quick ratio of 2.99, a current ratio of 3.58 and a debt-to-equity ratio of 0.41. The stock has a market cap of $11.21 billion, a price-to-earnings ratio of 21.03, a price-to-earnings-growth ratio of 2.61 and a beta of 0.98.

Revvity (NYSE:RVTY - Get Free Report) last posted its earnings results on Monday, July 28th. The company reported $1.18 EPS for the quarter, beating the consensus estimate of $1.14 by $0.04. Revvity had a return on equity of 7.73% and a net margin of 10.35%. The company had revenue of $720.28 million for the quarter, compared to the consensus estimate of $711.26 million. During the same quarter in the prior year, the business earned $1.22 earnings per share. The firm's revenue for the quarter was up 4.1% on a year-over-year basis. Analysts forecast that Revvity Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 17th will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.29%. The ex-dividend date is Friday, October 17th. Revvity's dividend payout ratio is currently 11.91%.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on RVTY shares. Wells Fargo & Company dropped their target price on Revvity from $130.00 to $102.00 and set an "equal weight" rating on the stock in a report on Thursday, April 17th. Barclays dropped their target price on Revvity from $140.00 to $110.00 and set an "overweight" rating on the stock in a report on Thursday, April 10th. Evercore ISI dropped their target price on Revvity from $116.00 to $115.00 and set an "outperform" rating on the stock in a report on Tuesday, July 8th. Bank of America dropped their target price on Revvity from $116.00 to $110.00 and set a "buy" rating on the stock in a report on Thursday, June 26th. Finally, Raymond James Financial reiterated an "outperform" rating and set a $120.00 target price (down previously from $145.00) on shares of Revvity in a report on Tuesday, April 29th. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $123.07.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.